Cardiac Imaging Software Market

Cardiac Imaging Software Market: Introduction

Cardiac imaging software is composed of special license programs that allow for the conversion of data into an analysis and visualization of images of the heart taken via modalities, such as MRI, CT, ultrasound, and nuclear medicine.

These solutions can be paramount in early diagnosis, monitoring, and management of cardiovascular diseases such as coronary artery disease, heart failure, arrhythmias, and valvular disorders by providing quantitative data and visualization with high resolution.

Furthermore, due to the increased awareness of patients and the rising importance attached to preventive cardiology, these diagnostic tests and monitoring processes are being performed more frequently. Prominent players like Canon Medical Systems and VitalConnect are intent on bringing improved AI-based cardiac imaging solutions into the market, focusing mainly on improving diagnostic accuracy and clinical workflow enhancement.

Furthermore, the cardiac imaging software market is anticipated to witness a surge owing to the prioritization of the early detection and effective management of cardiovascular diseases worldwide.

Growing demand for non-invasive diagnostic techniques is expected to drive Cardiac Imaging Software Market

The growing shift toward non-invasive and minimally invasive diagnostic techniques has resulted in enhancing the patient comfort and also reduce risks related to invasive methods.

For instance, in January 2024, AiMedic Inc.'s introduced HeartMedi+, which reduces the need for invasive exams by rapidly predicting coronary fractional flow reserve (FFR) using non-invasive CT-based simulations.

Moreover, in May 2024, GE HealthCare entered into partnership with Medis Medical Imaging to enhance non-invasive coronary evaluations by integrating Medis QFR into GE's Allia Platform.

Growing Prevalence of cardiovascular diseases is Attributed to Drive Overall Cardiac Imaging Software Market

Cardiovascular disorders (CVD), which are becoming more common, are amongst the main reasons people are admitted to hospitals across the globe The increasing healthcare expenditure for cardiovascular disease, rise in the aged population, technological advancements are expected to drive the overall upstream bioprocessing market in the upcoming period.

According to WHO, CVDs are the leading cause of morality worldwide, claiming 17.9 billion lives annually. More than 868,000 Americans lose their lives to heart disease or stroke each year, accounting for one-third of all fatalities, according to the National Center for Chronic Disease Prevention and Health Promotion.

Additionally, according to a research by RTI International, 131.2 billion Americans living with CVD, or 45% of the country’s population are expected to have cardiovascular disease in the years to come.

Therefore, the need for cardiac imaging software to recognize heart-related issues with the use of MRI, CT scan, angiography, radioactive materials, and the other types of radiant light rises with the occurrence of cardiovascular illnesses.

By Imaging Modality, Computed Tomography segment accounts for the Largest Share of Cardiac Imaging Software Industry

The computed tomography segment held the majority share in 2024 with respect to the cardiac imaging software market revenue. This is primarily owing to provision of efficiency in delivering doses of cancer tissue-damaging radiation as compared to conventional X-Rays. For instance, as per the RadioGraphics Organization published in 2023, the chest CT is involved in taking a probable role in the diagnosis, prognostications and detection of complications of the covid-19 pandemic.

North America to Lead Cardiac Imaging Software Market

North America cardiac imaging software market is expected to dominate the overall market in 2025 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing incidence of cardiovascular disease, rise in disposable income as well as the aging population across the region.

For instance, according to the CDC, heart disease is the leading cause of death for men, women, and individuals of various racial and ethnic groups. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. Additionally, in the United States, someone has a heart attack every 40 seconds.

Key Players

The major players operating in the global market are focusing on advancements in research and development to meet the rising demand for cardiac imaging software treatment. Moreover, manufacturers are entering into partnerships for the development of innovative products.

Key players operating in the global cardiac imaging software market include:

• FUJIFILM Holdings Corporation
• Koninklijke Philips N.V
• Siemens Healthineers AG
• GE HealthCare
• CANON MEDICAL SYSTEMS CORPORATION
• NeoSoft LLC
• Tempus AI Inc. (Arteys)
• Pie Medical Imaging B.V. (Esaote group)
• Medis Medical Imaging Systems B.V.
• Circle Cardiovascular Imaging Inc.
• Other Prominent Players

Cardiac Imaging Software Market Segmentation

• By Imaging Modality:
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound Imaging
  • SPECT
  • Others (X-Ray Imaging, etc.)
• By Application:
  • Diagnostic Imaging
  • Image Guided Treatment
• By End-user:
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others (Research Institutes, etc.)
• By Region:
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa